Evaluation of iron, ferritin, copper, and ceruloplasmin along with proviral load in human T lymphotropic virus type 1-associated myelopathy.
Copper
Ferritins
HAM/TSP
HTLV-1
Iron
Journal
Journal of neurovirology
ISSN: 1538-2443
Titre abrégé: J Neurovirol
Pays: United States
ID NLM: 9508123
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
received:
09
03
2020
accepted:
17
02
2021
revised:
15
01
2021
pubmed:
21
4
2021
medline:
28
4
2022
entrez:
20
4
2021
Statut:
ppublish
Résumé
Human T-cell lymphotropic virus type 1 (HTLV-1) infection can cause HTLV-I-associated myelopathy (HAM). In this study, we evaluated the levels of serum iron, ferritin, copper, and ceruloplasmin, and their correlations with HTLV-1 proviral load (PVL) and standard indices of HAM severity. In total, 114 subjects were recruited in this cross sectional study in Qaem Hospital, Mashhad, Iran between 2017 and 2018, including 36 HAM and 32 asymptomatic cases (ACs) and 46 healthy people (HSs). The clinical examination and evaluation of serum levels of biochemical factors and proviral load were performed. The PVL in HAM and ACs were 1835.49 ± 382.81 and 280.97 ± 67.41 copies/10
Identifiants
pubmed: 33877590
doi: 10.1007/s13365-021-00961-5
pii: 10.1007/s13365-021-00961-5
doi:
Substances chimiques
Copper
789U1901C5
Ferritins
9007-73-2
Iron
E1UOL152H7
Ceruloplasmin
EC 1.16.3.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
831-837Informations de copyright
© 2021. Journal of NeuroVirology, Inc.
Références
Armitage AE, Stacey AR, Giannoulatou E, Marshall E, Sturges P, Chatha K et al (2014) Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections. Proc Natl Acad Sci USA 111(33):12187–12192
doi: 10.1073/pnas.1402351111
Ashrafi F, Nassiri M, Javadmanesh A, Rahimi H, Rezaee SA (2020) Epigenetics evaluation of the oncogenic mechanisms of two closely related bovine and human deltaretroviruses: a system biology study. Microb Pathog 139:103845
doi: 10.1016/j.micpath.2019.103845
Bangham CR, Osame M (2005) Cellular immune response to HTLV-1. Oncogene 24(39):6035–6046. https://doi.org/10.1038/sj.onc.1208970 (PMID: 16155610)
doi: 10.1038/sj.onc.1208970
pubmed: 16155610
Biggar RJ, Ng J, Kim N, Hisada M, Li HC, Cranston B et al (2006) Human leukocyte antigen concordance and the transmission risk via breast-feeding of human T cell lymphotropic virus type I. J Infect Dis 193(2):277–282. https://doi.org/10.1086/498910 (PMID: 16362892)
doi: 10.1086/498910
pubmed: 16362892
Boostani R, Mellat Ardakani A, Ashrafi H (2011) Khorasan Disease: prevalence of HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) In West Azarbaijan from 2004 to 2007. Iran Red Crescent Med J 13(6):428–430. https://doi.org/10.1258/095646206778145541 (PMCID: PMC3371933, PMID: 22737507)
doi: 10.1258/095646206778145541
pubmed: 22737507
pmcid: 3371933
Bowlus CL (2003) The role of iron in T cell development and autoimmunity. Autoimmun Rev 2(2):73–78
doi: 10.1016/S1568-9972(02)00143-X
Cooper SA, van der Loeff MS, Taylor GP (2009) The neurology of HTLV-1 infection. Pract Neurol 9(1):16–26. https://doi.org/10.1136/jnnp.2008.167155 (PMID: 19151234)
doi: 10.1136/jnnp.2008.167155
pubmed: 19151234
Dinarello CA (2011) Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. blood-2010–07–273417. https://doi.org/10.1182/blood-2010-07-273417 (PMID: 21304099, PMCID: PMC3083294)
Drakesmith H, Prentice A (2008) Viral infection and iron metabolism. Nat Rev Microbiol 6(7):541. https://doi.org/10.1038/nrmicro1930 (PMID: 18552864)
doi: 10.1038/nrmicro1930
pubmed: 18552864
Ganz T, Nemeth E (2015) Iron homeostasis in host defence and inflammation. Nat Rev Immunol 15(8):500–510
doi: 10.1038/nri3863
Ghezeldasht SA, Shirdel A, Assarehzadegan MA, Hassannia T, Rahimi H, Miri R et al (2013) Human T lymphotropic virus type I (HTLV-I) oncogenesis: molecular aspects of virus and host interactions in pathogenesis of adult T cell leukemia/lymphoma (ATL). Iran J Basic Med Sci 16(3):179–195 (PMID: 24470860, PMCID: PMC3881257)
Ghezeldasht SA, Sadeghian H, Azarpazhooh MR, Shamsian SAA, Rafatpanah H, Mahmoodi M et al (2017) Evaluation of T regulatory lymphocytes transcription factors in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients. Appl Biochem Biotechnol 182(4):1403–1414. https://doi.org/10.1007/s12010-017-2406-7 (PMID:28101786)
doi: 10.1007/s12010-017-2406-7
pubmed: 28101786
Goncalves DU, Proietti FA, Barbosa-Stancioli EF, Martins ML, Ribas JG, Martins-Filho OA et al (2008) HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) inflammatory network. Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets-Inflammation & Allergy 7(2):98–107 (PMID: 18691139)
Grassi MFR, Olavarria VN, de Almeida Kruschewsky R, Yamano Y, Jacobson S, Taylor GP et al (2013) Utility of HTLV proviral load quantification in diagnosis of HTLV-1-associated myelopathy requires international standardization. Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 58(3):584 (PMCID: PMC4758193, NIHMSID: NIHMS757853, PMID: 24095029)
doi: 10.1016/j.jcv.2013.09.003
Kalavi K, Moradi A, Tabarraei A (2013) Population-based seroprevalence of HTLV-I infection in Golestan Province, South East of Caspian Sea, Iran. Iran J Basic Med Sci 16(3):225–228 (PMID: 24470867, PMCID: PMC3881256)
pubmed: 24470867
pmcid: 3881256
Kallianpur AR, Gittleman H, Letendre S, Ellis R, Barnholtz-Sloan JS, Bush WS et al (2019) Cerebrospinal fluid ceruloplasmin, haptoglobin, and vascular endothelial growth factor are associated with neurocognitive impairment in adults with HIV infection. Mol Neurobiol 56(5):3808–3818
doi: 10.1007/s12035-018-1329-9
Khan N, Chen X, Geiger JD (2020) Role of divalent Cations in HIV-1 replication and pathogenicity. Viruses 12(4):471
doi: 10.3390/v12040471
Lai H, Lai S, Shor-Posner G, Ma F, Trapido E, Baum MK (2001) Plasma zinc, copper, copper: zinc ratio, and survival in a cohort of HIV-1-infected homosexual men. J Acquir Immune Defic Syndr (1999) 27(1):56–62 (PMID: 11404521)
doi: 10.1097/00042560-200105010-00010
Lee P, Peng H, Gelbart T, Wang L, Beutler E (2005) Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci 102(6):1906–1910 (PMCID: PMC548537, PMID: 15684062)
doi: 10.1073/pnas.0409808102
Lezin A, Olindo S, Olière S, Varrin-Doyer M, Marlin R, Cabre P et al (2005) Human T lymphotropic virus type I (HTLV-I) proviral load in cerebrospinal fluid: a new criterion for the diagnosis of HTLV-I–associated myelopathy/tropical spastic paraparesis? J Infect Dis 191(11):1830–1834. https://doi.org/10.1086/429962
doi: 10.1086/429962
pubmed: 15871115
Mohammad-Reza HM (2013) Seroepidemiology of human T-cell lymphotropic virus type 1 infection in Iran: An overview. (PMCID: PMC4664977, PMID: 26556363)
Moreno T, Artacho R, Navarro M, Perez A, Ruiz-Lopez M (1998) Serum copper concentration in HIV-infection patients and relationships with other biochemical indices. Sci Total Environ 217(1–2):21–26 (PMID: 9695170)
doi: 10.1016/S0048-9697(98)00158-2
Morgan DJ, Caskey MF, Abbehusen C, Oliveira-Filho J, Araujo C, Porto AF et al (2007) Brain magnetic resonance imaging white matter lesions are frequent in HTLV-I carriers and do not discriminate from HAM/TSP. AIDS Res Hum Retrovir 23(12):1499–1504. https://doi.org/10.1089/aid.2007.0077 (PMID: 18160007, PMCID: PMC2593463)
doi: 10.1089/aid.2007.0077
pubmed: 18160007
Orland JR, Engstrom J, Fridey J, Sacher RA, Smith JW, Nass C et al (2003) Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology 61(11):1588–1594 (PMID: 14663047, PMCID: PMC3074002)
doi: 10.1212/01.WNL.0000096011.92542.DA
Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F, Bidkhori HR, Shamsian SK, Ahmadi S et al (2011) High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. J Clin Virol 52(3):172–176. https://doi.org/10.1016/j.jcv.2011.07.004 (PMID: 21840754)
doi: 10.1016/j.jcv.2011.07.004
pubmed: 21840754
Rafatpanah H, Rezaee A, Etemadi MM, Hosseini RF, Khorram B, Afsahr L et al (2012) The impact of interferon-alpha treatment on clinical and immunovirological aspects of HTLV-1-associated myelopathy in northeast of Iran. J Neuroimmunol 250(1–2):87–93 (PMID 22727800)
doi: 10.1016/j.jneuroim.2012.05.004
Ruddell RG, Hoang‐Le D, Barwood JM, Rutherford PS, Piva TJ, Watters DJ et al (2009) Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB–regulated signaling in rat hepatic stellate cells. Hepatology 49(3):887–900. https://doi.org/10.1002/hep.22716 (PMID: 19241483, PMCID: PMC2701483)
doi: 10.1002/hep.22716
pubmed: 19241483
Shan Y, Lambrecht RW, Bonkovsky HL (2005) Association of hepatitis C virus infection with serum iron status: analysis of data from the third National Health and Nutrition Examination Survey. Clin Infect Dis 40(6):834–841. https://doi.org/10.1086/428062 (PMID: 15736017)
doi: 10.1086/428062
pubmed: 15736017
Smirnov IM, Bailey K, Flowers CH, Garrigues NW, Wesselius LJ (1999) Effects of TNF-α and IL-1β on iron metabolism by A549 cells and influence on cytotoxicity. Am J Physiol Lung Cell Mol Physiol 277(2):L257–L263 (PMID: 10444519)
doi: 10.1152/ajplung.1999.277.2.L257
Watanabe T (2011) Current status of HTLV-1 infection. Int J Hematol 94(5):430–434. https://doi.org/10.1007/s12185-011-0934-4 (PMID: 21969187)
doi: 10.1007/s12185-011-0934-4
pubmed: 21969187